An observation of weight gain in patients with atopic dermatitis receiving dupilumab
Our findings suggest that dupilumab treatment in AD may be associated with weight gain in a subset of patients. Given the emerging role of IL-4 in metabolic regulation, further prospective studies are warranted to clarify the mechanism and clinical significance of this potential adverse effect.
Authors
- Darren Roche (ORCID: https://orcid.org/0000-0003-1010-4367)
- Donal O’Shea (ORCID: https://orcid.org/0000-0002-1408-5274)
- Ali Alsharqi
- Brian Kirby (ORCID: https://orcid.org/0000-0001-7596-892X)
Institutions
- University College Dublin (IE)
- Tallaght University Hospital (IE)
- St. Vincent's University Hospital (IE)
- Institute of Dermatology (TH)
Publication Details
- Journal
- Clinical and Experimental Dermatology
- Published
- 2025-06-27
- DOI
- https://doi.org/10.1093/ced/llaf292
- Primary Topic
- Dermatology and Skin Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00